¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"metabolic disease"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • Roussy-Levy disease
    ·ç½Ã-·¹ºñº´
  • runt disease
    ·±Æ®º´, ¼Ò¸ðº´
  • rat-bite disease
    Áã¹°¸²º´
  • Raynaud¡¯s disease
    ·¹À̳뺴
  • recessive hereditary disease
    ¿­¼ºÀ¯Àüº´
  • Refsum¡¯s disease
    ·¹ÇÁ¼ûº´
  • renal disease
    ÄáÆÏº´, ½ÅÀ庴
  • reported communicable disease
    ½Å°íµÈÀü¿°º´
  • respiratory disease
    È£Èí±âÁúȯ
  • reversible obstructive lung disease
    °¡¿ªÆó¼âÆóº´, °¡¿ªÆó¼âÆóÁúȯ
  • rheumatic disease
    ·ù¸¶Æ¼½ºº´
  • rheumatoid disease
    ·ù¸¶Æ¼½º¸ð¾çÁúȯ
  • rice disease
    ½Òº´, °¢±âº´
  • rickettsial disease
    ¸®ÄÉÂ÷º´
  • Ritter¡¯s disease
    ¸®Åͺ´
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • spinocerebellar disease
    ô¼ö¼Ò³úº´
  • spirochetal disease
    ½ºÇÇ·ÎÇ쟺´
  • sterility disease
    ºÒÀÓº´
  • storage disease
    ÃàÀûº´
  • subclinical disease
    ºÒÇö¼ºº´
  • systemic disease
    Àü½Åº´
  • thoracic disease
    °¡½¿º´, ÈäºÎÁúȯ
  • tick-borne disease
    Áøµå±â¸Å°³º´
  • trophoblastic disease
    ¿µ¾ç¸·º´
  • tropical disease
    ¿­´ëº´
  • tsutsugamushi disease
    ÂêÂê°¡¹«½Ãº´
  • tubulointerstitial disease
    ¿ä¼¼°ü»çÀÌÁúÁúȯ, ¿ä¼¼°ü°£Áúº´
  • upper respiratory disease
    »ó±âµµº´
  • uremic medullary cystic disease
    ¿äµ¶¼ÓÁú³¶º´
  • valvular heart disease
    ÆÇ¸·½ÉÀ庴
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • hemoglobin h disease
    Ç÷»ö¼Ò H º´
  • hemoglobinopathy =abnormal hemoglobin disease
    Ç÷»ö¼Òº´Áõ.
  • hemolytic disease
    ¿ëÇ÷¼º Áúȯ(¡­òðü´).
  • hemolytic disease
    ¿ëÇ÷¼º Áúȯ
  • hemolytic disease of fetus/newborn
    žÆ/½Å»ý¾Æ¿ëÇ÷¼º Áúȯ
  • hemolytic disease of newborn
    ½Å»ý¾Æ¿ëÇ÷¼º Áúȯ.
  • hemolytic disease of newborn
    ½Å»ý¾Æ ¿ëÇ÷¼º Áúȯ
  • hemolytic disease of newborn
    ½Å»ý¾Æ¿ëÇ÷¼º Áúȯ.
  • hemorrhagic disease
    ÃâÇ÷(¼º) Áúȯ.
  • hemorrhagic disease
    ÃâÇ÷¼ºÁúȯ
  • hemorrhagic disease of newborn
    ½Å»ý¾ÆÃâÇ÷(¼º) Áúȯ.
  • hemp disease
    ¸¶¼¶À¯º´.
  • hepatolenticular disease
    °£·»ÁîÇÙÁúȯ.
  • hepatolienal disease
    °£ºñÁúȯ.
  • hereditary disease
    À¯Àüº´.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • disease
    Áúº´(Ü»), Áúȯ(òðü´)
  • disease
    º´, Áúº´, Áúȯ
  • disease
    º´(Ü»), Áúº´(òðÜ»), Áúȯ(òðü´).
  • disease
    º´(ËÓ), Áúº´(̤ËÓ), Áúȯ(̷̤).
  • disease carrier
    º´¿ø(ü)º¸À¯ÀÚ(Ü»êÂô÷ÜÁêóíº).
  • disease carrier
    º´¿ø(ü)º¸À¯ÀÚ(ËÓËô̧ËÓËôËö).
  • disease control
    Áúº´°ü¸®.
  • disease detection
    Áúº´¹ß°ß.
  • disease entity
    Áúº´´ÜÀ§(òðܻӤêÈ).
  • disease entity
    Áúº´´ÜÀ§(̤ËÓËÀËô).
  • disease free interval
    ¹«º´±â°£
  • disease free survival
    ¹«º´»ýÁ¸
  • disease potential
    Áúº´ÀáÀç·Â.
  • disease prevention
    Áúº´¿¹¹æ(¡­çãÛÁ).
  • disease prevention
    Áúº´¿¹¹æ(ÊÙËçËÑ).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 20
MRD maximum rate of depolarization; measles-rindenpest-distemper [virus group]; medical records departme...
MVD Doctor of Veterinary Medicine; microvascular decompression; mitral valve disease; multivessel corona...
NAD neutrophil actin dysfunction; new antigenic determinant; nicotinamide adenine dinucleotide; nicotini...
OD Doctor of Optometry; obtained absorbance; occipital dysplasia; occupational dermatitis; occupational...
OHD hydroxyvitamin D; Office of Human Development; Ondine-Hirschsprung disease; organic heart disease
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 20
CLD Chronic Lung Disease
COAD Chronic Obstructive Airway Disease
COLD Chronic Obstructive Lung Disease
COPD Chronic Obstructive Lung Disease
COPD Chronic Obstructive Pulmonary Disease
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • von Willebrand disease
    von Willebrand Áúȯ
  • von Willebrand's disease
    Æù ºô¸®ºê¶õÆ® º´, Æùºô·¹ºê¶õµåº´
    ¼±Ãµ¼º À¯Àü¼º ¼ÒÁú·Î, »ó¿°»öü¼º ¿ì¼º ÇüÁú·Î À¯ÀüµÇ¸ç ÃâÇ÷ ½Ã°£ÀÇ ¿¬Àå, ÀÀ°í ÀÎÀÚ 8ÀÇ °áÇÌÀ» Ư¡À¸·Î ÇÑ´Ù. ºñ ÃâÇ÷°ú °ü·ÃÀÌ ÀÖÀ¸¸ç ¿Ü»ó ȤÀº ¼ö¼ú ÈÄÀÇ ÃâÇ÷, ¿ù°æÃâÇ÷, ºÐ¸¸ ÈÄ ÃâÇ÷ µîÀÌ ÇöÀúÈ÷ Áõ°¡ÇÑ´Ù..
  • wasting disease
    ¼Ò¸ðº´
  • weber christian disease
    ¿þ¹ö-Å©¸®½ºÂùº´
  • Weber-Christian disease °áÀý¼º, ºñÈ­³ó¼º, ÇÇÇÏ Áö¹æÁ¶Á÷ÀÇ ¿°Áõ.

    Weber-Cocayne syndrome

    ¿þ¹ö ÄÚÄÉÀÎ ÁõÈıº
    ±¹ÇѼºÀÇ Ç¥ÇÇ ¼öÆ÷Áõ.
  • Weil's disease Ȳ´Þ ÃâÇ÷¼º ·¾Å佺ÇǶóÁõ.

    Weinrich et Emmerson

    ¼è¼¼¸ðÆí¸ðÃæ
  • Werlhof disease
    º£¸¦È£ÇÁ º´
    ÇǺο¡ ÃâÇ÷À» º¼ ¼ö ÀÖ´Â Àڹݺ´ÀÇ Çϳª·Î¼­ Ư¹ß¼º Ç÷¼ÒÆÇ °¨¼Ò¼º Àڹݺ´, ÃâÇ÷¼º Àڹݺ´À̶ó°íµµ ÇÑ´Ù. ÇǺγª Á¡¸·
  • wernicke's disease
    º£¸£´ÏÄɺ´
    µ¿ÀǾî=
  • whipple's disease Èí¼öºÎÀü ÁõÈıºÀ¸·Î ¼³»ç, Áö¹æ º¯Áõ, ÇǺλö¼Ò Ä§Âø, °üÀý¿°, °üÀýÅë, ¸²ÇÁÀý¿°, ÁßÃ߽Űæ°èÀå¾Ö°¡ Ư¡ÀÌ´Ù.

    Whipple's triad

    ÇÇÇþ¾ »ï¡ÈÄ
    ¿øÀο¡ °ü°è¾øÀÌ ¸ðµç ÀúÇ÷´çÁõÀÇ Æ¯Â¡À¸·Î 1
  • white finger disease
    ¹é¶øº´
    ¾ÐÃà°ø±â, ÇØ¸Ó, Àüµ¿ Åé µî ¼Õ¿¡ Áã°í Á¶ÀÛÇÏ´Â Áøµ¿°ø±¸ÀÇ Áøµ¿À¸·Î ¼ÕÀÇ µ¿¸ÆÀÌ Àå¾Ö¸¦ ¹Þ¾Æ °©Àڱ⠼հ¡¶ôÀÌ Ã¢¹éÇØÁö´Â º´. »çÁö ¸»´Ü, ƯÈ÷ ¼öÁöÀÇ Ç÷°üÀå¾Ö·Î ÁßÁõÀÏ ¶§´Â ȯºÎ°¡ ±«»ç¿¡ ºüÁö´Â Á÷¾÷º´À¸·Î ·¹À̳ë ÁõÈıºÀÇ ÇÑ º´ÇüÀ¸·Î °£ÁÖÇϰí ÀÖ´Ù. ¿øÀÎÀº Ç÷°ü ¿îµ¿ ½Å°æ Àå¾Ö·Î ÀÎÇÑ µ¿¸Æ ¼öÃà ¶§¹®¿¡ ÀϾ´Â Ç÷·ù Àå¾ÖÀÌ´Ù. Áõ¼¼´Â ¹ßÀÛÀûÀ¸·Î ÀϾ ¼Õ°¡¶ôÀÌ Ã¢¹éÇØÁö¸ç, ÅëÁõ°ú Àú¸®´Â °¨ÀÌ ÀÖ°í, ÀÌ¾î º¸¶ó»öÀ¸·Î º¯Çß´Ù°¡ ºÓ¾îÁö¸é¼­ ȸº¹µÇ¸ç, ÀÌ »çÀÌ´Â ¼öºÐ ³»Áö ¼ö ½Ê ºÐÀ̰í Ãß¿ï ¶§ ¸¹´Ù. Ä¡·á´Â Ç÷°üÈ®ÀåÁ¦¸¦ »ç¿ëÇÏ°í ¼ÕÀ» Â÷Áö ¾Ê°Ô º¸¿Â¿¡ ÁÖÀÇÇϸç, °ø±¸ »ç¿ëÀº ÀÏÁ¤ ±â°£ »ï°¡´Â °ÍÀÌ ÁÁ´Ù.
  • woolsorters disease
    ¾ç¸ð¾÷ÀÚº´
    ¾ç¸ð¸¦ Ãë±ÞÇÏ´Â »ç¶÷¿¡¼­ º¼ ¼ö ÀÖ´Â ÆóÀÇ ÅºÀú·Î, B. anthrax¸¦ ÈíÀÔÇÔÀ¸·Î½á ÀϾ´Ù.
  • Zahorsky's disease
    ÀÚÈ£¸£½ºÅ° º´
    À¯¾Æ¿¡¼­ º¼ ¼ö ÀÖ´Â µ¹¹ß¼º ¹ßÁø.
  • Ziehen-Oppengeim disease
    Á¦¿£-¿ÀÆæÇÏÀÓº´
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
Centers for Disease Control and Prevention <organisation> The U.S. Public health agency serving as the centre for preventing, tracking controlling and investigating the epidemiology of AIDS and other diseases.
(26 Mar 1998)
central core disease A congenital myopathy characterised by hypotonia, delay of motor development in infancy, and nonprogressive or slowly progressive muscle weakness; on biopsy the central core of muscle fibres stains abnormally, myofibrils are abnormally compact, and there is virtual absence of mitochondria and sarcoplasmic reticulum; histochemically, the cores are devoid of oxidative enzyme, phosphorylase, and ATPase activity; autosomal dominant inheritance, often subclinical.
(05 Mar 2000)
central core disease of muscle <neurology> One of the conditions that produces floppy baby syndrome. It causes hypotonia (floppiness) in the newborn baby, slowly progressive muscle weakness, and muscle cramps after exercise.
Muscle biopsy shows a key diagnostic finding (absent mitochondria in the centre of many type I muscle fibres). The disease is inherited as a dominant trait. The CCD gene is on chromosome 19 (and involves ryanodine receptor-1).
Inheritance: autosomal dominant.
(12 Dec 1998)
Vogt-Spielmeyer disease Cerebral sphingolipidosis, late juvenile type.
Synonym: Vogt-Spielmeyer disease.
(05 Mar 2000)
medullary cystic disease <disease> A rare hereditary kidney disease characterised by the gradual loss of kidney function due to the presence of cysts in the renal medulla.
Symptoms include high urine output (cannot concentrate the urine), weakness, weight loss, nocturia, fatigue and headache. There is no cure and usually progresses from chronic renal failure to end stage renal disease.
(27 Sep 1997)
medullary cystic kidney disease <radiology> Mode of inheritance uncertain, usually affects young adults (early 20s), associated with red or blond hair (!!), causes salt wasting, polyuria, azotaemia, affects both kidneys, with progressive disease patients need dialysis or transplant
(12 Dec 1998)
central Recklinghausen's disease type II type 1 neurofibromatosis
Centres for Disease Control The federal facility for disease eradication, epidemiology, and education headquartered in Atlanta, Georgia, which encompasses the Centre for Infectious Diseases, Centre for Environmental Health, Centre for Health Promotion and Education, Centre for Prevention Services, Centre for Professional Development and Training, and Centre for Occupational Safety and Health. Formerly named Centre for Disease Control (1970), Communicable Disease Centre (1946).
(05 Mar 2000)
centres for disease control and prevention See: CDC.
(12 Dec 1998)
Voltolini's disease Disease of the labyrinth, leading to deafmutism, in young children.
(05 Mar 2000)
Pel-Ebstein disease The remittent fever common in Hodgkin's disease.
Synonym: Pel-Ebstein disease.
(05 Mar 2000)
Pelizaeus-Merzbacher disease A sudanophilic leukodystrophy with a tigroid appearance of the myelin resulting from patchy demyelination. Type 1-classic, nystagmus and tremor appearing in the first few months of life, followed by slow motor development sometimes with choreoathetosis, spasticity, optic atrophy and seizures, with death in early adulthood, X-linked recessive inheritance; type 2-contralateral form with death in months to years after birth, X-linked recessive inheritance; type 3-transitional, with death in the first decade; type 4-adult form associated with involuntary movements, ataxia and hyperreflexia, but without nystagmus; type 5-variant forms. Cockayne is sometimes included as a sixth form.
Synonym: Merzbacher-Pelizaeus disease.
(05 Mar 2000)
Pellegrini's disease A calcific density in the medial collateral ligament and/or bony growth at the internal condyle of the femur.
Synonym: Pellegrini-Stieda disease.
(05 Mar 2000)
Pellegrini-Stieda disease A calcific density in the medial collateral ligament and/or bony growth at the internal condyle of the femur.
Synonym: Pellegrini-Stieda disease.
(05 Mar 2000)
glycogen storage disease <hepatology> A group of inherited metabolic disorders involving the enzymes responsible for the synthesis and degradation of glycogen. In some patients, prominent liver involvement is presented. In others, more generalised storage of glycogen occurs, sometimes with prominent cardiac involvement.
Synonym: glycogenosis
(12 Sep 2002)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 20
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 20
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 20
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 20
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 20
ÅëÇÕ°Ë»ö ¿Ï·á